The phase 3 STEER trial showed that a single intrathecal dose of onasemnogene abeparvovec significantly improved motor function in children and adolescents with spinal muscular atrophy versus sham, with a similar and acceptable safety profile.
- Crystal M. Proud
- Dũng Chí Vũ
- Yuh-Jyh Jong